Indivior | Netto Inntekt



Net Income Endring Dato
AstraZeneca USD 1.5B 71M 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
Halozyme Therapeutics USD 137.01M 1000 2024-12
Indivior 4M 111M 2024-09
J&J USD 11B 7.57B 2025-03
Kyowa Hakko Kirin JPY 18.12B 5.02B 2024-09
Merck USD 3.74B 586M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 410M 4.06B 2024-12
Sanofi EUR 499M 2.32B 2024-12
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12



Indivior Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.